3rd Quarter - Report — HARM REDUCTION COALITION for HARM REDUCTION COALITION (2012)

Firm

HARM REDUCTION COALITION

Client

HARM REDUCTION COALITION

Income

—

Expenses

$20,000

Expense method

A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Prescription drug abuse and overdose prevention. Access to naloxone. Hepatitis C research, testing and treatment

Lobbyist	Covered position, as disclosed
WHITNEY ENGLANDER	—

Contacted: Food & Drug Administration (FDA); Centers For Disease Control & Prevention (CDC); SENATE; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS); Office of Natl Drug Control Policy (NDCP); HOUSE OF REPRESENTATIVES

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.